[1]
Raffaele Borghini et al. 2019. Further improvement after 24-month treatment with teduglutide in a patient with active Crohn’s disease and short bowel syndrome. Turkish Journal of Gastroenterology. 29, 2 (Jul. 2019), 249–250.